FDA recall, , Moderate risk
Mississippi Blood Services Red Blood Cells, Leukocytes Reduced
Red blood cells were collected from a donor with low hemoglobin or without a hemoglobin check.
Recall ended Sep 21, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Mississippi Blood Services Inc. recalled 2 units of Red Blood Cells, Leukocytes Reduced because they were collected from a donor with hemoglobin lower than acceptable, or who had no hemoglobin check performed during screening. The recall began on August 29, 2025, and was added to the FDA's Enforcement Report on September 21, 2026. The affected products were distributed in Mississippi.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Mississippi Blood Services Inc.
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98849
- Recall number
- B-0200-2026
- Quantity recalled
- 2 units
All recalls from Mississippi Blood Services Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
